954239-58-8 Usage
Uses
Used in Pharmaceutical Research and Development:
1-HYDROXYMETHYL-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID TERT-BUTYL ESTER is used as a chemical intermediate for the synthesis of new drugs, leveraging its potential biological and pharmacological properties to address a variety of diseases and conditions.
Used in Drug Discovery for Neurological Disorders:
In the field of neurology, 1-HYDROXYMETHYL-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID TERT-BUTYL ESTER is used as a lead compound for developing treatments targeting neurological disorders, due to its potential to interact with biological systems relevant to these conditions.
Used in Drug Development for Oxidative Stress-Related Conditions:
1-HYDROXYMETHYL-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID TERT-BUTYL ESTER is utilized as a key component in the development of drugs aimed at combating oxidative stress-related conditions, capitalizing on its ability to mitigate the effects of oxidative stress on the body.
Used in the Enhancement of Pharmaceutical Formulations:
The tert-butyl ester group in 1-HYDROXYMETHYL-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID TERT-BUTYL ESTER is used to improve the stability and compatibility of pharmaceutical formulations, ensuring that the compound can be effectively incorporated into various drug delivery systems.
Check Digit Verification of cas no
The CAS Registry Mumber 954239-58-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,4,2,3 and 9 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 954239-58:
(8*9)+(7*5)+(6*4)+(5*2)+(4*3)+(3*9)+(2*5)+(1*8)=198
198 % 10 = 8
So 954239-58-8 is a valid CAS Registry Number.
InChI:InChI=1/C15H21NO3/c1-15(2,3)19-14(18)16-9-8-11-6-4-5-7-12(11)13(16)10-17/h4-7,13,17H,8-10H2,1-3H3
954239-58-8Relevant academic research and scientific papers
CRYSTAL FORM OF (R)-PRAZIQUANTEL AND PREPARATION METHOD AND APPLICATION THEREOF
-
, (2016/10/11)
The present invention relates to a crystal form of (R)-praziquantel and a preparation method and uses thereof. The X-ray diffraction pattern (CuKα radiation) of the crystal form of (R)-praziquantel at 25° C. shows the following diffraction peaks: 2-Theta=
